Home / Products / Peptides / Details
video
Tirzepatide Peptide Raw Powder

Tirzepatide Peptide Raw Powder

Appearance: White to off-white powder
Specification: 98% min
CAS Number: 2023788-19-2
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight: 4813
EINECS: 200-001-8
Shelf Life: 2 Years Proper Storage
Stock: Fresh Stock
Certificate: COA,GMP,ISO,HACCP
Service: OEM&ODM Service

Product Introduction

Factory Direct Tirzepatide Peptide Raw Powder, Customizable Specifications for R&D Key Benefits:

High-purity, stable, and bioactive Tirzepatide Peptide Raw Powder GIP/GLP-1 dual receptor agonist peptide API.

● Supports metabolic regulation, blood glucose control, and weight management.

● Ideal for R&D of type 2 diabetes, obesity, and obstructive sleep apnea (OSA) therapies.

● Comes with full compliance documentation to meet global pharmaceutical development, pharmacology, and academic research needs.

 

Product Overview

 

Tirzepatide Peptide Raw Powder for injectable and oral formulation development (CAS: 2023788-19-2) is the world's first and only approved GIP/GLP-1 dual receptor agonist peptide API. It is composed of 39 amino acids and optimized with a C20 fatty acid side chain. It exhibits dual receptor activation, long half-life, and high bioavailability, making it fully compatible with injectable and oral formulation development.

 

Manufactured using hybrid SPPS/LPPS fragment synthesis, continuous flow reactions, and nanofiltration purification, Tirzepatide Peptide Raw Powder adheres strictly to GMP and ICH pharmaceutical raw material standards. It is suitable for small-scale and pilot-scale research, formulation screening, pharmacology, toxicology, and pharmacokinetic studies. This peptide API supports innovative and generic drug development for type 2 diabetes, obesity.

 

COA

 

Item Specification Result
Appearance White or off-white powder; Freely soluble in water Conforms
pH 6.0~9.0 6.6
Water Content ≤7.0% 2.30%
Acetic Acid ≤0.5% ND
Trifluoroacetic Acid ≤0.5% ND
Sodium Ion ≤5.0% 1.00%
Residual Solvents Methanol≤0.3% ND
Dichloromethane≤0.06% ND
Acetonitrile≤0.041% 0.01%
DMF≤0.088% ND
Bacterial Endotoxin The endotoxin in each 1mg of Tirzepatide shall be less than 5EU Conforms
Assay 95.0%~105.0% 102.20%
Assay of Peptide ≥85.0% 95.80%
Conclusion The product complies with the requirements.

 

 

Mechanism of Action

 

Tirzepatide Peptide Raw Powder mimics and enhances endogenous GLP-1 and GIP actions:

● Glucose-dependent insulin secretion

● Glucagon suppression

● Appetite suppression, delayed gastric emptying, increased satiety

● Pancreatic β-cell protection and proliferation

● Long-acting weekly dosing with stable bioactivity

 

Product Applications

 

R&D of type 2 diabetes therapies (subcutaneous injections, oral forms)

● Development of obesity, OSA, and metabolic disorder drugs 

● Pharmacology, pharmacokinetics, and toxicology studies targeting GLP-1/GIP pathways

● Pharmaceutical intermediates for global compliant trade, supporting bulk procurement overworld

● Academic research on metabolic pharmacology, peptide therapeutics, and receptor mechanism

 

Benefits of Tirzepatide Peptide Raw Powder

 

● Powerful Hypoglycemic Activity – Activates both GLP-1 and GIP receptors, enhancing insulin secretion, suppressing glucagon, and lowering fasting and postprandial blood glucose.

● Multiple Metabolic Benefits – Appetite suppression, weight reduction, improved insulin resistance, β-cell protection, and lipid regulation.

● Stable Bioavailability – Optimized molecular structure ensures high absorption and minimizes plasma concentration fluctuation, ideal for R&D and pilot production.

● Chemical & Physical Stability – Resistant to hydrolysis and oxidation, maintains long-term bioactivity under proper storage, suitable for research, clinical trials, and scaled production.

● Unique Dual Mechanism – First approved GIP/GLP-1 dual receptor peptide with synergistic metabolic regulation and reduced gastrointestinal side effects.

 

Core Advantages 

 

1. High Purity & Stability for type 2 diabetes and metabolic disorder R&D: Purity ≥99.0% (tested by HPLC), stable chemical properties, long-term storage under standard conditions.

2. Strong Targeting & Efficacy: Dual GLP-1/GIP receptor agonist, effective metabolic regulation and research results.

3. Good Solubility & Bioavailability: Soluble in DMSO and ethanol, ensuring stable and reliable experimental results.

4. Wide Application & Safety: Suitable for pharmaceutical R&D, scientific research, low immunogenicity, safe and non-irritating.

5. Compliant with Industry Standards: Meets USP/BP quality standards, suitable for international procurement and pilot-scale R&D.

 

Quality Assurance 

 

● GMP-Compliant Manufacturing: Amino acid selection, synthesis, modification, purification, and packaging.

● Full Batch Traceability: Each batch fully documented, traceable, and audit-ready.

● Professional Storage & Cold Chain: Vacuum-sealed, ≤-20°C, moisture and oxidation protected.

● Post-Sales Support: Bioactivity testing, solubility guidance, storage instructions, and troubleshooting.

 

FAQ

 

Q1: Can Tirzepatide Peptide Raw Powder be used for commercial drug production?
A1: Suitable for small- and pilot-scale research. For commercial production, comply with target country regulations and obtain appropriate regulatory-grade material.

 

Q2: How is solubility and post-dissolution stability?
A2: White/off-white powder; dissolves in saline/buffer; clear solution, stable bioactivity for ≥1 month at 2–8°C.

 

Q3: How is bioactivity assured?
A3: Retained via advanced molecular modification and freeze-drying; verified by HPLC and dedicated activity testing; guidance provided for storage and reconstitution.

 

Q4: Is there immunogenicity risk?
A4: Retains peptide sequences; preclinical studies show <5% antibody positivity; low immunogenicity; suitable for long-term formulation development.

 

factory

Tirzepatide Peptide Raw Powder GMP Manufacturing Factory Cleanroom Peptide Production Facility

High Purity Tirzepatide Peptide API Bulk Production Pharmaceutical Grade Manufacturing Workshop

Tirzepatide Raw Powder Advanced Peptide Synthesis Factory Direct Supply China Manufacturer

 

Certificates

Tirzepatide Peptide Raw Powder COA Certificate HPLC Tested High Purity Analysis Report

GMP ISO Certified Tirzepatide Peptide API Quality Assurance Compliance Certificate Laboratory Verified

Shipping & Packing

 

Tirzepatide Peptide Raw Powder Vacuum Sealed Packaging Pharmaceutical Grade Bulk Supply Export Package

 

Call to Action

 

Tirzepatide Peptide Raw Powder for injectable, oral, and research-grade formulation development supports stable physicochemical properties, rigorous quality control, complete documentation, and flexible supply, enabling efficient global type 2 diabetes, obesity, and OSA R&D. Contact us for pricing, bulk orders, sample requests, COA files, or custom supply solutions.

 

Contact:

Whatsapp & Mobile: +8619991242181
Email:
sales@hdmbio.com

Hot Tags: tirzepatide peptide raw powder, China tirzepatide peptide raw powder manufacturers, suppliers, factory, Cetrorelix Acetate Powder, Myelin Oligodendrocyte Glycoprotein 35 55, N Acetyl Selank Amidate, Oxytocin Powder, SS 31 Peptide Powder, Testagen Peptide Powder

Send Inquiry

Home

Phone

E-mail

Inquiry

Bag